“So the Chinese labs have thrown a lifeline to the Western loss-making labs, and I just have no clue as to why.”
I don’t think it is intentional but this is actually quite bad for the western labs.
The entire booster narrative has been “look at how their revenue is growing! $10bn to $100bn ARR in under a year! This’ll be a multi-trillion IPO!” and the extrapolated future growth from $100bn to $500bn and $500bn to $1tn justified future investment… but that revenue was just because inference was expensive.
The revenue growth story is all that matters pre-IPO. If revenue falls from $100bn to $50bn that’s very very bad optics for OpenAI and Anthropic even if they are now profitable, it completely destroys the growth narrative.
I don't see why revenue has to fall even if marginal costs drop off a cliff. As long as they have the best models (perceived or otherwise) and can make security and IP guarantees that satisfy enterprise, and no firm with similar guarantees undercuts them on price (why would they want a race to the bottom?) they can have high revenue and high margin.
reticulates · · focus · HN ↗
I don’t think it is intentional but this is actually quite bad for the western labs.
The entire booster narrative has been “look at how their revenue is growing! $10bn to $100bn ARR in under a year! This’ll be a multi-trillion IPO!” and the extrapolated future growth from $100bn to $500bn and $500bn to $1tn justified future investment… but that revenue was just because inference was expensive.
The revenue growth story is all that matters pre-IPO. If revenue falls from $100bn to $50bn that’s very very bad optics for OpenAI and Anthropic even if they are now profitable, it completely destroys the growth narrative.
DangitBobby · · focus · HN ↗
dominotw · · focus · HN ↗
DangitBobby · · focus · HN ↗